Skip to content

Author

Anna Mingazzini

1 paper indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Current Perspectives on the Use of Adjuvant Pembrolizumab for Hepatocellular Carcinoma

Abstract Despite implementation of surveillance in at-risk populations and the availability of potentially curative treatment such as resection or ablation, recurrence of hepatocellular carcinoma (HCC) remains a frequent clinical challenge driven by both occult residual disease and de novo carcinogenesis, and can have...

Anna Mingazzini, Daniel Riado Minguez, Ylenia Babini et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.